Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
FDA review spotlights risk of heart inflammation linked to Novavax's Covid vaccine — shares tumble
3 years ago
FDA+
Pfizer, like Moderna, fires back at Alnylam suit over Covid-19 vaccine patents
3 years ago
Pharma
Law
'Vaccines alone are insufficient': Merck, Aligos work with academic experts to find Covid antivirals as part of $65M NIH grant
3 years ago
Discovery
Research revamp: UK calls on clinical trial sponsors to shut down trials that aren't viable
3 years ago
R&D
Covid-19 roundup: Moderna reclaims vaccine marketing rights in Japan; New IP waiver draft
3 years ago
Pharma
Switzerland to destroy over 600,000 expired doses of Moderna Covid vaccine
3 years ago
Pharma
Manufacturing
Covid-19 roundup: CDC study shows good protection from mRNA booster plus J&J's single-dose vaccine; White House launches test-to-treat Paxlovid site
3 years ago
Saying goodbye to R&D chief, Flagship-backed Axcella drops PhII program as it focuses on long Covid, NASH
3 years ago
People
R&D
Covid-19 roundup: NRx's med gets axed from NIH trial over futility; A new drug for the pandemic enters the clinic
3 years ago
Updated: US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
3 years ago
Moderna seeks to dismiss Alnylam suit over Covid-19 vaccine component, claiming wrong venue
3 years ago
Law
Covid-19 roundup: Serum Institute eyes Africa for global expansion — report; Junshi antiviral hits primary endpoint in late-stage trial
3 years ago
Third dose bumps up efficacy of Pfizer-BioNTech's Covid-19 vaccine in youngest group of children to 80%
3 years ago
As GSK-partnered Covid antibody racks up global sales, Vir axes WuXi deal and grabs back China rights
3 years ago
Deals
China
Covid-19 roundup: WHO validates another shot; Ashish Jha chimes in on the state of vaccines and therapeutics
3 years ago
Pharma
Amid rising concern of resistance, Pfizer limits supply of Paxlovid for combination studies — report
3 years ago
Pharma
FDA authorizes booster dose of Pfizer and BioNTech's Covid-19 vaccine in 5- to 11-year-olds
3 years ago
Pharma
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
3 years ago
Deals
Unpersuaded by the data, FDA rejects cheap, generic SSRI as a Covid-19 drug
3 years ago
FDA+
Covid-19 roundup: Synairgen turns to post-hoc analyses after failed drug trial; EU terminates Valneva vaccine contract
3 years ago
Global license program to receive Covid-19 support from the NIH
4 years ago
Pharma
Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say
4 years ago
Covid-19 roundup: Cancer biotech to submit EUA for Covid drug; FDA OKs Eli Lilly JAK inhibitor
4 years ago
Emergent tossed nearly 400M Covid-19 vaccine doses in Baltimore debacle, House report says
4 years ago
Pharma
Manufacturing
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page